Bionano Genomics, Inc. (BNGO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$0.27

P/E Ratio

N/A

Market Cap

$27.56M

Description

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerBNGO
  • Price$0.2702-3.40%

Trading Information

  • Market cap$27.56M
  • Float99.49%
  • Average Daily Volume (1m)13,480,924
  • Average Daily Volume (3m)6,519,746
  • EPS-$2.31

Company

  • Revenue$33.33M
  • Rev growth (1yr)-34.83%
  • Net income-$44.25M
  • Gross margin-139.07%
  • EBITDA margin-374.13%
  • EBITDA-$22.72M
  • EV$38.48M
  • EV/Revenue1.15
  • P/EN/A
  • P/S0.70
  • P/B0.49
Documents